Company Profiles

driven by the PitchBook Platform

Artax Biopharma

Description

Developer of next generation therapies designed to serve the patients of autoimmune and inflammatory diseases. The company's next generation therapies discover new variety of drugs that target the interaction point between T-cell Receptors (TCR) and Nck, enabling patients to get themselves cured from wide range of autoimmune and inflammatory diseases.

2013

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$10M

Latest Deal Amount

$12M

Total Amount Raised

Description

Developer of next generation therapies designed to serve the patients of autoimmune and inflammatory diseases. The company's next generation therapies discover new variety of drugs that target the interaction point between T-cell Receptors (TCR) and Nck, enabling patients to get themselves cured from wide range of autoimmune and inflammatory diseases.

Website:

www.artaxbiopharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

1 Broadway, 14th floor Cambridge, MA 02142United States +1 (617) 330-7000
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Artax Biopharma's full profile, request a free trial.

    Artax Biopharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Artax Biopharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Artax Biopharma Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Advent Life SciencesVenture CapitalMinority000 0000000 0000
    A. M. Pappas & AssociatesOtherMinority000 0000000 0000
    Henri TermeerAngel (individual)Minority000 0000000 0000
    Advent Life Sciences Venture Capital
    A. M. Pappas & Associates Other
    Henri Termeer Angel (individual)

    Artax Biopharma Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Balbino Alarcón Ph.DChief Scientific Officer
    Andy Gagete Ph.DDirector, Research & Development
    Damià Tormo Ph.DCo-Founder, Board Member & Chief Executive Officer
    Balbino Alarcón Ph.D Chief Scientific Officer
    Andy Gagete Ph.D Director, Research & Development
    Damià Tormo Ph.D Co-Founder, Board Member & Chief Executive Officer

    Artax Biopharma Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Damià Tormo Ph.DSelfCo-Founder, Board Member & Chief Executive Officer000 0000
    Gino SantiniSelfBoard Member000 0000
    Henri Termeer Ph.DSelfBoard Member000 0000
    Javier GarcíaArtax BiopharmaBoard Member & Executive, Business Development000 0000
    Rajesh Parekh Ph.DAdvent Life SciencesGeneral Partner000 0000
    Damià Tormo Ph.D Co-Founder, Board Member & Chief Executive Officer Self
    Gino Santini Board Member Self
    Henri Termeer Ph.D Board Member Self
    Javier García Board Member & Executive, Business Development Artax Biopharma
    Rajesh Parekh Ph.D General Partner Advent Life Sciences
    Request full access to PitchBook